Prevention & Chronic Conditions

About

Cardiovascular disease (CVD) is a significant and ever-growing problem in the UK, accounting for nearly one-third of all deaths and leading to significant morbidity. Globally CVD accounts for 31% of mortality, mainly from heart disease and cerebrovascular accident.

The burden of CVD can be ameliorated by careful risk modification and primary prevention is an important priority for all developers of health policy. Strong consensus exists between international guidelines regarding the necessity of smoking cessation, weight optimisation and exercise, although guidelines have slightly different approaches to hypertension and vary considerably regarding their approach to optimal lipid profile, which remains a contentious issue.

Articles

The Role of Oral Vasoactive Agents in the Treatment of Pulmonary Arterial Hypertension

Citation:

US Cardiology 2006;3(1):1–5

The US Cardiovascular Arena-In Brief A Round-up of Trends, Statistics and Clinical Research

Citation:

US Cardiology 2006;3(2):12–3

Underutilization of Aspirin Persists in US Ambulatory Care for the Secondary and Primary Prevention of Cardiovascular Disease

Citation:

US Cardiology 2006;3(1):1–7

Evaluation and Diagnosis of Pulmonary Arterial Hypertension

Citation:

US Cardiology 2005;2(1):1–6